Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Signosis is a private life science tools company that develops and commercializes molecular bioassays, biomarker detection kits, stable reporter cell lines, and related research reagents for biomedical research and drug discovery. The company focuses on transcription factor analysis, cytokine ELISA products, oxidative stress and metabolism assays, gene regulation tools, and customized assay services. Its offerings are used by academic, government, and biopharma research organizations for biomarker discovery, pathway profiling, and translational research rather than for development of proprietary therapeutics. Based in Santa Clara, California, Signosis appears to operate as an active commercial supplier of research-use products in the biotechnology and healthcare research ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Signosis.